A Phase 1 Clinical Trial to Explore Systemic Exposure of CTO0101 Eye Drops, Safety and Local Tolerability in Healthy Adults
Latest Information Update: 07 Feb 2024
At a glance
- Drugs CTO 0101 (Primary)
- Indications Eye disorders
- Focus Pharmacokinetics
- Sponsors Taejoon Pharm
Most Recent Events
- 08 Mar 2022 New trial record